Skip to main content
HomeDrug Comparisons
Drug bottle and Pill

Compare Olumiant vs. Rinvoq

Head-to-head comparisons of medication uses, side effects, warnings, and more.

  • Olumiant (baricitinib)
    Rinvoq (upadacitinib)
  • Olumiant (baricitinib)
    Rinvoq (upadacitinib)

  • Summary of Olumiant vs. Rinvoq

    Summary for JAK inhibitor
    Prescription only

    Olumiant (baricitinib) is a Janus kinase (JAK) inhibitor. It's used to treat rheumatoid arthritis (RA) and severe hair loss (alopecia areata) in adults. It can also be prescribed for adults hospitalized with COVID-19 who need breathing support. Olumiant (baricitinib) is taken by mouth once daily. The most common side effect of this medication is a higher risk of infections.

    Summary for JAK inhibitor
    Prescription only

    Rinvoq (upadacitinib) is a Janus kinase (JAK) inhibitor. It's used to treat certain inflammatory conditions, such as rheumatoid arthritis (RA), ulcerative colitis (UC), and eczema (atopic dermatitis). But it's not a first-choice option and typically only prescribed when other treatments haven't worked well. Rinvoq (upadacitinib) is taken by mouth, usually once daily. It's available as an extended-release tablet (Rinvoq) and an oral solution (Rinvoq LQ), but the two formulations aren't interchangeable. Side effects include a higher risk of infections, acne, and nausea.

  • Indications of Olumiant vs. Rinvoq

    Indications for
    •Moderate-to-severe rheumatoid arthritis (RA) in adults
    •COVID-19 in hospitalized adults who need oxygen or support from machines to help breathe
    •Severe hair loss (alopecia areata) in adults
    Indications for

    Moderate-to-severe inflammatory conditions in which other treatments haven't worked:

    •Rheumatoid arthritis (RA) in adults
    •Psoriatic arthritis (PsA) in adults and children ages 2 years and older
    •Eczema (atopic dermatitis) in adults and children ages 12 years and older
    •Ulcerative colitis (UC) in adults
    •Crohn's disease (CD) in adults
    •Ankylosing spondylitis (AS) in adults
    •Non-radiographic axial spondyloarthritis (nr-axSpA) in adults
    •Polyarticular juvenile idiopathic arthritis (pJIA) in adults and children ages 2 years and older

  • Pros and Cons of Olumiant vs. Rinvoq

    Pros and Const for JAK inhibitor
    Pros
    •Works well for rheumatoid arthritis, COVID-19, and alopecia areata
    •The only JAK inhibitor FDA-approved for COVID-19
    •Taken once per day
    •Can be taken with or without food
    Cons
    •Not a good option for people with severe liver and kidney problems
    •Can cause low blood cell counts and raise the risk of infection
    •It's not clear how safe it is when taken during pregnancy or breastfeeding
    Pros and Const for JAK inhibitor
    Pros
    •Can treat many different inflammatory conditions
    •Available as a tablet and a liquid
    •The tablet only needs to be taken once a day
    Cons
    •Can raise risk for infections
    •Not the best option for people with severe liver or kidney problems
    •Not safe for use during pregnancy

  • Common Side Effects of Olumiant vs. Rinvoq

    Common Side Effects for

    Rheumatoid arthritis:

    •Upper respiratory infection (up to 16%)

    COVID-19:

    •Raised liver enzymes (9-18%)
    •Infections (up to 9%)

    Alopecia areata:

    •Upper respiratory infection (18-21%)
    •Headache (6-7%)
    •Acne (6%)
    •High cholesterol (4-6%)
    •Urinary tract infection (4%)
    Common Side Effects for
    •Upper respiratory tract infection (25%)
    •Acne (16%)
    •Herpes simplex virus (HSV) infection (8%)
    •Headache (6%)

    Note: Side effects listed were reported by people who took Rinvoq for eczema.

  • Warnings of Olumiant vs. Rinvoq

    Common Side Effects for
    •Serious infections
    •Possible higher risk of death
    •Possible risk of cancer
    •Risk of heart attack, stroke, and other blood clots
    •Severe allergic reactions
    •Tears in the gut
    •Changes in lab tests
    Common Side Effects for
    •Serious infections
    •Possible higher risk of death for people with rheumatoid arthritis
    •Risk of cancer
    •Possible risk of heart attack, stroke, and other blood clots
    •Severe allergic reaction
    •Stomach and gut tears
    •Abnormal lab results (e.g., blood cell counts, cholesterol levels)
    •Possible harm to unborn babies
    •Medication in stool

  • Prices with our coupons for Olumiant vs. Rinvoq

    Learn more about Olumiant
    Learn more about Rinvoq

Compare other Rheumatoid Arthritis drugs

Olumiant vs RinvoqDupixent vs AdbryDupixent vs FasenraDupixent vs SymbicortDupixent vs XolairEntyvio vs HumiraEntyvio vs OrtikosEntyvio vs RinvoqEntyvio vs SkyriziEntyvio vs StelaraEticovo vs RinvoqInflectra vs EntyvioOrencia vs RinvoqRemicade vs EntyvioRemicade vs RinvoqRinvoq vs ActemraRinvoq vs CibinqoRinvoq vs CimziaRinvoq vs CosentyxRinvoq vs DupixentRinvoq vs EnbrelRinvoq vs HumiraRinvoq vs OtezlaRinvoq vs SimponiRinvoq vs SkyriziRinvoq vs XeljanzRinvoq vs ZeposiaStelara vs RinvoqTremfya vs EntyvioZeposia vs Entyvio
View More

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.